APA

Vincenti F., Mendez R., Pescovitz M., Rajagopalan P. R., Wilkinson A. H., Butt K., Laskow D., Slakey D. P., Lorber M. I., Garg J. P. & Garovoy M. (20070808). A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation. : American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Chicago

Vincenti F, Mendez R, Pescovitz M, Rajagopalan P R, Wilkinson A H, Butt K, Laskow D, Slakey D P, Lorber M I, Garg J P and Garovoy M. 20070808. A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation. : American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Harvard

Vincenti F., Mendez R., Pescovitz M., Rajagopalan P. R., Wilkinson A. H., Butt K., Laskow D., Slakey D. P., Lorber M. I., Garg J. P. and Garovoy M. (20070808). A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation. : American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

MLA

Vincenti F, Mendez R, Pescovitz M, Rajagopalan P R, Wilkinson A H, Butt K, Laskow D, Slakey D P, Lorber M I, Garg J P and Garovoy M. A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation. : American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 20070808.